Inari Medical, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Inari Medical, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2019 to Q3 2024.
  • Inari Medical, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $13M, a 31.6% increase year-over-year.
  • Inari Medical, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $48.7M, a 27.6% increase year-over-year.
  • Inari Medical, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $40.3M, a 40.7% increase from 2022.
  • Inari Medical, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $28.7M, a 12.7% increase from 2021.
  • Inari Medical, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $25.4M, a 622% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $48.7M $13M +$3.11M +31.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-28
Q2 2024 $45.6M $13M +$2.69M +25.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-30
Q1 2024 $42.9M $12.9M +$2.53M +24.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-30
Q4 2023 $40.3M $9.8M +$2.21M +29% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $38.1M $9.84M +$2.49M +33.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-28
Q2 2023 $35.6M $10.4M +$3.19M +44.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-30
Q1 2023 $32.5M $10.3M +$3.78M +57.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-30
Q4 2022 $28.7M $7.6M +$3.09M +68.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $25.6M $7.36M -$5.14M -41.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $30.7M $7.16M +$2.56M +55.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $28.2M $6.56M +$2.72M +70.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $25.4M $4.51M +$2.94M +188% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $22.5M $12.5M +$11.5M +1203% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $11M $4.6M +$4.1M +812% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $6.87M $3.84M +$3.34M +677% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $3.52M $1.57M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $959K +$819K +585% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $505K +$406K +410% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $494K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q3 2019 $140K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $99K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.